Mirae Asset Small Cap Fund
The scheme seeks to generate capital appreciation by investing predominantly in small cap stocks. From time to time, the fund manager will also seek participation in other equity and equity related securities to achieve optimal portfolio construction.
Growthvine rating: 2/5 — ranked #24 of 37 in category.
Fund basics
| Category | Equity: Small Cap |
|---|
| NAV | ₹12.26 (as of 2026-10-01) |
|---|
| AUM | ₹5,221 Cr |
|---|
| Expense ratio | 1.58% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Varun Goel |
|---|
| Exit load | For units in excess of 15% of the investment, 1% will be charged for redemption within 365 days |
|---|
Performance & risk
| Standard deviation | 0.00% |
|---|
| Max drawdown | −15.60% |
|---|
| Alpha | 0 |
|---|
| Beta | 0 |
|---|
Over 5 years, captured 90.3% of NIFTY Smallcap 250's upside and 68.4% of its downside.
Market cap allocation
| Large cap | 5.8% |
|---|
| Mid cap | 15.2% |
|---|
| Small cap | 79.0% |
|---|
Concentration
| Top 5 holdings | 11.6% |
|---|
| Top 10 holdings | 21.2% |
|---|
| Total holdings | 83 |
|---|
| Index overlap | 23.1% |
|---|
| Active share | 76.9% |
|---|
Top holdings
- Welspun Corp Limited — 2.8%
- TREPS — 2.4%
- Karur Vysya Bank Ltd. — 2.3%
- Kirloskar Oil Engines Limited — 2.2%
- Dr. Lal Pathlabs Limited — 2.2%
- K.P.R. Mill Ltd. — 2.0%
- VOLTAMP TRANSFORMERS LIMITED — 2.0%
- Neuland Laboratories Limited. — 2.0%
- Anthem Biosciences Limited — 1.9%
- GNG Electronics Limited — 1.9%
Top sectors
- Banking & Financial — 13.4%
- Industrial Products — 12.0%
- Pharma & Biotech — 10.1%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | 5.9% | Q3 | #25 of 34 |